Competing with the big players through smart IP practices.
As a New Zealand exporter of animal health products, Bomac’s competitors include large multinationals like Pfizer, Merial and Shering Plough. With a range of new products being developed every year, they needed to be innovative in every way in order to compete.
Bomac consulted with James & Wells on a regular basis to ensure their products did not infringe specific IP rights overseas, to keep abreast of competitors’ IP activities and to align the business goals and strategies accordingly.
Bomac’s comprehensive and innovative IP portfolio was a major factor in its attractiveness to global giant Bayer, who acquired it in 2010.
"Kate has focused the whole organisation on innovation and inventiveness; it has become part of our culture and the whole team is cognisant of the value generated by appropriate protection. We now see intellectual property as a key factor in our success".
Wayne Leech, Director, Bomac Laboratories Limited
